Private Advisor Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Private Advisor Group’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-42,850	Closed	-$198K	–	1918
2020 Q2	$198K	Sell	42,850 -9,809	-19%	-$44.1K	﹤0.01%	1371
2020 Q1	$203K	Sell	52,659 -15,000	-22%	-$61.6K	﹤0.01%	1227
2019 Q4	$254K	Buy	67,659 +17,250	+34%	+$80.7K	﹤0.01%	1353
2019 Q3	$268K	Buy	+50,409	New	+$269K	﹤0.01%	1350
2017 Q1	–	Sell	-24,500	Closed	-$28K	–	1417
2016 Q4	$28K	Buy	+24,500	New	+$28K	﹤0.01%	1248

Other funds holding CPRX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Private Advisor Group's CPRX Position: Q3 2020 in Review

Private Advisor Group sold out of Catalyst Pharmaceutical (CPRX) in Q3 2020, closing a stake of 42,850 shares — an estimated $198K sold.

Private Advisor Group first reported a position in CPRX in Q4 2016 and held it in 5 quarters. The position peaked at $268K in Q3 2019. 142 funds tracked by Wall St. Rank hold CPRX as of Q3 2020.

Private Advisor Group reported no remaining Catalyst Pharmaceutical position as of Q3 2020 after selling out during the quarter.
Private Advisor Group sold 42,850 Catalyst Pharmaceutical shares in Q3 2020, an estimated $198K.
Private Advisor Group first reported a position in Catalyst Pharmaceutical in Q4 2016 and held it in 5 quarters.
Private Advisor Group's Catalyst Pharmaceutical position peaked at $268K in Q3 2019.
142 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.